AU2001266399A1 - Oral drug composition containing a verapamil derivative as drug-absorption promotor - Google Patents
Oral drug composition containing a verapamil derivative as drug-absorption promotorInfo
- Publication number
- AU2001266399A1 AU2001266399A1 AU2001266399A AU6639901A AU2001266399A1 AU 2001266399 A1 AU2001266399 A1 AU 2001266399A1 AU 2001266399 A AU2001266399 A AU 2001266399A AU 6639901 A AU6639901 A AU 6639901A AU 2001266399 A1 AU2001266399 A1 AU 2001266399A1
- Authority
- AU
- Australia
- Prior art keywords
- drug
- composition containing
- absorption promotor
- oral
- verapamil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR0046643 | 2000-08-11 | ||
KR1020000046643A KR20020013174A (en) | 2000-08-11 | 2000-08-11 | Oral composition for enhancing absorbability of a drug of which absorption rate in oral administration is low |
PCT/KR2001/001096 WO2002013815A1 (en) | 2000-08-11 | 2001-06-27 | Oral drug composition containing a verapamil derivative as a drug-absorption promotor |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001266399A1 true AU2001266399A1 (en) | 2002-02-25 |
Family
ID=19682856
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001266399A Abandoned AU2001266399A1 (en) | 2000-08-11 | 2001-06-27 | Oral drug composition containing a verapamil derivative as drug-absorption promotor |
Country Status (6)
Country | Link |
---|---|
US (1) | US20020049158A1 (en) |
EP (1) | EP1184034A3 (en) |
JP (1) | JP2002080399A (en) |
KR (1) | KR20020013174A (en) |
AU (1) | AU2001266399A1 (en) |
WO (1) | WO2002013815A1 (en) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI275594B (en) * | 2001-08-24 | 2007-03-11 | Theravance Inc | Process for preparing vancomycin phosphonate derivatives |
KR100503161B1 (en) * | 2002-07-18 | 2005-07-25 | 한미약품 주식회사 | Novel p-glycoprotein inhibitor, method for preparing same and oral composition comprising same |
KR20040008816A (en) * | 2002-07-19 | 2004-01-31 | 한미약품 주식회사 | A pharmaceutical oral composition for preventing restenosis which comprises paclitaxel or derivative thereof and p-glycoprotein inhibitor |
KR100533458B1 (en) * | 2002-07-20 | 2005-12-07 | 대화제약 주식회사 | Composition for solubilization of paclitaxel and preparation method thereof |
KR100573289B1 (en) * | 2002-07-20 | 2006-04-24 | 대화제약 주식회사 | Paclitaxel composition for the intravesical treatment of bladder tumor and preparation method thereof |
KR100503889B1 (en) * | 2002-07-20 | 2005-07-26 | 한국과학기술연구원 | Absorption enhancer of anticancer drugs |
KR20040047056A (en) * | 2002-11-29 | 2004-06-05 | 한미약품 주식회사 | Oral micro-emulsion composition comprising biphenyldimethyldicarboxylate |
KR100638041B1 (en) * | 2003-12-24 | 2006-10-23 | 주식회사 삼양사 | A nanoparticle composition of a water-soluble drug for oral administration and a preparation method thereof |
KR100678829B1 (en) * | 2004-12-06 | 2007-02-05 | 한미약품 주식회사 | Oral micro-emulsion composition comprising tacrolimus |
KR101391020B1 (en) * | 2005-03-14 | 2014-04-30 | 가부시키가이샤 오츠까 세이야꾸 고죠 | Pharmaceutical composition containing hardly water soluble medicament |
KR100712823B1 (en) * | 2006-02-23 | 2007-05-02 | 한국유나이티드제약 주식회사 | The solubilized coenzyme q10 soft capsules composition and the producing method thereof |
NZ581589A (en) * | 2007-06-22 | 2012-10-26 | Scidose Llc | Solubilized sterile injectable formulation of docetaxel without Tween 80 |
US20090088393A1 (en) * | 2007-09-28 | 2009-04-02 | Zomanex, Llc | Methods and formulations for converting intravenous and injectable drugs into oral dosage forms |
KR20100121505A (en) * | 2008-03-07 | 2010-11-17 | 싸이도우스 엘엘씨. | Fulvestrant formulations |
US20110092579A1 (en) * | 2009-10-19 | 2011-04-21 | Scidose Llc | Solubilized formulation of docetaxel |
US8912228B2 (en) | 2009-10-19 | 2014-12-16 | Scidose Llc | Docetaxel formulations with lipoic acid |
US8541465B2 (en) * | 2009-10-19 | 2013-09-24 | Scidose, Llc | Docetaxel formulations with lipoic acid and/or dihydrolipoic acid |
US7772274B1 (en) | 2009-10-19 | 2010-08-10 | Scidose, Llc | Docetaxel formulations with lipoic acid |
US11179468B2 (en) | 2012-04-09 | 2021-11-23 | Eagle Pharmaceuticals, Inc. | Fulvestrant formulations |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998053811A1 (en) * | 1997-05-27 | 1998-12-03 | Baker Norton Pharmaceuticals, Inc. | Method and compositions for administering taxanes orally to human patients |
EP0822815A4 (en) * | 1996-01-31 | 1998-04-01 | Bristol Myers Squibb Co | A method of making pharmaceutically active taxanes orally bioavailable |
KR100245981B1 (en) * | 1997-10-04 | 2000-04-01 | 김충섭 | Compound having inhibitory effect on antitumor agent resistance, process of preparation thereof and pharmaceutical composition for inhibition on antitumor agent resistance comprising same |
US6268377B1 (en) * | 1998-09-28 | 2001-07-31 | Merck & Co., Inc. | Method for treating androgen-related conditions |
-
2000
- 2000-08-11 KR KR1020000046643A patent/KR20020013174A/en not_active Application Discontinuation
-
2001
- 2001-05-08 EP EP01111018A patent/EP1184034A3/en not_active Withdrawn
- 2001-05-11 US US09/854,051 patent/US20020049158A1/en not_active Abandoned
- 2001-06-27 WO PCT/KR2001/001096 patent/WO2002013815A1/en active Search and Examination
- 2001-06-27 AU AU2001266399A patent/AU2001266399A1/en not_active Abandoned
- 2001-07-09 JP JP2001207750A patent/JP2002080399A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
KR20020013174A (en) | 2002-02-20 |
EP1184034A2 (en) | 2002-03-06 |
US20020049158A1 (en) | 2002-04-25 |
WO2002013815A1 (en) | 2002-02-21 |
JP2002080399A (en) | 2002-03-19 |
EP1184034A3 (en) | 2002-11-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001266399A1 (en) | Oral drug composition containing a verapamil derivative as drug-absorption promotor | |
AU2276801A (en) | Extended release oral dosage composition | |
AU2277101A (en) | Stable extended release oral dosage composition | |
IL148357A0 (en) | Pharmaceutical compositions containing a benzamide derivative | |
AU6089200A (en) | Rapid immediate release oral dosage form | |
AU2001286581A1 (en) | Dental composition for hypersensitive teeth | |
AU2002222118A1 (en) | Pharmaceutical compositions for inhalation | |
HUP0202495A3 (en) | Stable medicinal compositions for oral use | |
AU2003276549A1 (en) | Pharmaceutical compositions containing a biguanide-glitazone combination | |
HUP0301390A3 (en) | Oral pharmaceutical composition containing valsartan | |
AU2001262733A1 (en) | Medicinal compositions containing propenone derivatives | |
AU2001284444A1 (en) | Preparations for oral administration | |
AU2001290239A1 (en) | Medicinal composition | |
IL161143A0 (en) | A flash-melt pharmaceutical oral dosage composition | |
AU2001225164A1 (en) | Compositions with enhanced oral bioavailability | |
IL148169A0 (en) | Pharmaceutical compositions containing a benzamide derivative | |
AU1732401A (en) | Medicinal compositions for oral use | |
AU2002215114A1 (en) | Pharmaceutical compositions for inhalation | |
AU2001270235A1 (en) | Oral compositions | |
AU7887400A (en) | A slow release pharmaceutical composition | |
AU4085201A (en) | Pharmaceutical composition | |
AU2001246778A1 (en) | A composition containing monoterpenes for topical oral administration | |
AU2001290669A1 (en) | Oral compositions | |
EP1210935A4 (en) | Medicinal compositions for oral use | |
AU2001278487A1 (en) | Oral composition |